Literature DB >> 15260944

Patient and family attitudes toward schizophrenia treatment.

Farzin Irani1, Mary Dankert, Steven J Siegel.   

Abstract

Patient and family member attitudes toward illness, psychopharmacologic and nonpharmacologic treatments in schizophrenia, as well as their attitudes toward psychiatric research are reviewed here. The authors' recent work investigating patient and family member attitudes toward illness, medication, and a new method of receiving medication via surgical implants is also presented. The authors highlight the importance of understanding patient attitudes so that individual treatment plans and new treatments for schizophrenia can be facilitated. The important contribution of family members in caring for their loved ones is also emphasized. Patient participation in biomedical research is also discussed in the context of guiding the treatment of schizophrenia.

Entities:  

Mesh:

Year:  2004        PMID: 15260944     DOI: 10.1007/s11920-004-0078-9

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   8.081


  39 in total

1.  Decisional capacity for informed consent in schizophrenia research.

Authors:  W T Carpenter; J M Gold; A C Lahti; C A Queern; R R Conley; J J Bartko; J Kovnick; P S Appelbaum
Journal:  Arch Gen Psychiatry       Date:  2000-06

2.  Patient perspectives on once-weekly fluoxetine.

Authors:  R Judge
Journal:  J Clin Psychiatry       Date:  2001       Impact factor: 4.384

3.  Predictors of burden and infectious illness in schizophrenia caregivers.

Authors:  D G Dyck; R Short; P P Vitaliano
Journal:  Psychosom Med       Date:  1999 Jul-Aug       Impact factor: 4.312

4.  Attitudes towards neuroleptic treatment: reliability and validity of the attitudes towards neuroleptic treatment (ANT) questionnaire.

Authors:  O Kampman; K Lehtinen; V Lassila; E Leinonen; O Poutanen; A Koivisto
Journal:  Schizophr Res       Date:  2000-10-27       Impact factor: 4.939

5.  Public attitude towards psychiatric treatment.

Authors:  M C Angermeyer; H Matschinger
Journal:  Acta Psychiatr Scand       Date:  1996-11       Impact factor: 6.392

6.  Ordinary logic in unordinary lay theories: a key to understanding proneness to medication nonadherence in schizophrenia.

Authors:  Liora Navon; Nili Ozer
Journal:  Arch Psychiatr Nurs       Date:  2003-06       Impact factor: 2.218

7.  [Schizophrenia: subjective illness theories--an explorative study. 1: Patients].

Authors:  F M Stark; R Stolle
Journal:  Psychiatr Prax       Date:  1994-03

8.  Concurrent and predictive validity of a self-reported measure of medication adherence.

Authors:  D E Morisky; L W Green; D M Levine
Journal:  Med Care       Date:  1986-01       Impact factor: 2.983

Review 9.  New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis.

Authors:  Stefan Leucht; Kristian Wahlbeck; Johannes Hamann; Werner Kissling
Journal:  Lancet       Date:  2003-05-10       Impact factor: 79.321

10.  Schizophrenia patients' and psychiatrists' perspectives on ethical aspects of symptom re-emergence during psychopharmacological research participation.

Authors:  Laura Weiss Roberts; Teddy D Warner; Khanh P Nguyen; Cynthia M A Geppert; Melinda K Rogers; Brian B Roberts
Journal:  Psychopharmacology (Berl)       Date:  2003-05-17       Impact factor: 4.530

View more
  2 in total

1.  WPA guidance on how to combat stigmatization of psychiatry and psychiatrists.

Authors:  Norman Sartorius; Wolfgang Gaebel; Helen-Rose Cleveland; Heather Stuart; Tsuyoshi Akiyama; Julio Arboleda-Flórez; Anja E Baumann; Oye Gureje; Miguel R Jorge; Marianne Kastrup; Yuriko Suzuki; Allan Tasman
Journal:  World Psychiatry       Date:  2010-10       Impact factor: 49.548

2.  How do close others to those with anxiety feel about treatment? Development and validation of the Treatment Concerns Questionnaire-Close Others.

Authors:  Olivia A Merritt; Karen Rowa; Christine L Purdon
Journal:  Cognit Ther Res       Date:  2022-07-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.